4//SEC Filing
McCann Corey 4
Accession 0001062993-21-012388
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:23 PM ET
Size
9.2 KB
Accession
0001062993-21-012388
Insider Transaction Report
Form 4
McCann Corey
DirectorPresident and CEO
Transactions
- Award
Class A Common Stock
2021-12-03+8,157,656→ 8,157,656 total - Award
Class A Common Stock
2021-12-03+1,685,913→ 1,685,913 total(indirect: By Trust) - Award
Class A Common Stock
2021-12-03+986,517→ 986,517 total(indirect: By Trust)
Footnotes (6)
- [F1]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 5,540,268 shares of common stock of Private Pear previously held by Dr. McCann.
- [F2]Received in accordance with the terms of the Business Combination Agreement in exchange for 1,145,000 shares of common stock of Private Pear previously held by The Corey M. McCann Irrevocable Trust of 2021.
- [F3]Received in accordance with the terms of the Business Combination Agreement in exchange for 670,000 shares of common stock of Private Pear previously held by The McCann Family Trust.
- [F4]The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
- [F5]Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
- [F6]Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881049
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:23 PM ET
- Size
- 9.2 KB